Top compounds associated with response to NIF3L1


Feature Type Standardized
Nominal ANOVA
mRNA alvocidib CTRPv2 pan-cancer AAC 0.14 0.005
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.005
mRNA phloretin CTRPv2 pan-cancer AAC 0.095 0.006
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.081 0.006
mRNA YM201636 GDSC1000 pan-cancer AAC 0.087 0.006
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.006
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.1 0.006
mRNA parbendazole CTRPv2 pan-cancer AAC 0.085 0.006
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.085 0.007
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.27 0.007
Download CSV